Not as positive about $20.00 this year as thats hundreds of percent above the current--but $10.00---yes I could see that this year? But the sales must continue to accelerate into cash flow positive ASAP!
Still its ready to attack its 52 week high off depressed valuation! If successfulon the attack----this could be playing with $6.00 this quarter. IMO.
Bad numbers reported could cause this to fall back too? its pretty clear the system for selling is partially on autopilot now and hospitals keep finding the advantages of this drug incorporated into their treatment regimens.
And CADX has not penetrated into all hospitals yet.
Cut sales force down to 1/3-1/4 and cut district managers down to 1/2. Keep clinical associates. After being on almost all FL Ofirmev will sell itself, no need for expensive marketing. Every doc knows everything about acetaminophen. The name of the game is making money. Make some partnership and put up "for sale" sign....